(Q28421466)

English

TYMS 5' TANDEM REPEAT

genetic variant

5' TANDEM REPEAT

In more languages

Statements

5 Prime UTR Variant

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/265

Short Tandem Repeat Variation

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/265

human chromosome 18

genomic assembly

Genome assembly GRCh37

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/265

657604

genomic assembly

Genome assembly GRCh37

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/265

657742

genomic assembly

Genome assembly GRCh37

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/265

biological variant of

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/265

negative therapeutic predictor for

fluorouracil / irinotecan combination therapy

determination method

CIViC evidence level B

CIViC 3-star trust rating

medical condition treated

colorectal cancer

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/evidence/678

UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy

Identifiers

CIViC variant ID

1 reference

23 May 2022

https://civic.genome.wustl.edu/links/variants/265

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28421466&oldid=2014800707"